Screener
Acadia Pharmaceuticals ACAD Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Acadia Pharmaceuticals’s reported figures.
The source filing: Acadia Pharmaceuticals’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333243
FAQ
- What is Acadia Pharmaceuticals's free cash flow?
- Acadia Pharmaceuticals (ACAD) reported free cash flow of $95.69M in Q2 2026.
- How has Acadia Pharmaceuticals's free cash flow changed year-over-year?
- Acadia Pharmaceuticals's free cash flow increased by 50.3% year-over-year, from $63.66M to $95.69M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Acadia Pharmaceuticals's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude